Back to Results
First PageMeta Content
Endocrine system / Peptide hormones / Recombinant proteins / Medicine / Humulin / Insulin analog / NPH insulin / Insulin therapy / Insulin aspart / Eli Lilly and Company / Diabetes / Biology


PREFERRED STEP THERAPY POLICY Insulin (Short- and Intermediate-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Humulin® R (Regular insulin human injection, USP [
Add to Reading List

Document Date: 2014-05-05 10:56:55


Open Document

File Size: 75,99 KB

Share Result on Facebook

City

Plansboro / Indianapolis / Tampa / /

Company

Eli Lilly / Eli Lilly and company / Gold Standard Inc. / Lilly / /

Event

Product Issues / /

IndustryTerm

Search terms / diabetes management algorithm / Diabetes Care / /

MedicalCondition

comprehensive diabetes / nocturnal hypoglycemia / hyperglycemia / diabetes / diabetes mellitus / hypoglycemia / /

MedicalTreatment

insulin injections / Pharmacotherapy / insulin therapy / /

Organization

American Association of Clinical Endocinologists / American Diabetes Association / American Association of Clinical Endocrinologists / /

/

Product

Humulin N / NovoLog Mix / Humalog Mix / Regular insulin / Novolin / BID injections / Novolin N / Humulin / Novolin R / Humulin R / NPH insulin / duration / /

Technology

recombinant DNA / diabetes management algorithm / /

URL

http /

SocialTag